Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acriflavine delivery via Polyurethane nanocapsules to treat neovascular age-related macular degeneration.

bioRxiv : the preprint server for biology·2026
Same author

Framework to Select Multi-Cancer Detection Assays in the National Cancer Institute's Vanguard Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

Delivery of Tempol from Polyurethane Nanocapsules to Address Oxidative Stress Post-Injury.

Bioconjugate chemistry·2025
Same author

Bioconjugates for Cancer Prevention: Opportunities for Impact.

Bioconjugate chemistry·2024
Same author

Polyester Nanoparticles and Polyurethane Nanocapsules Deliver Pirfenidone To Reduce Fibrosis and Scarring.

ACS biomaterials science & engineering·2023
Same author

Azithromycin Protects Retinal Glia Against Oxidative Stress-Induced Morphological Changes, Inflammation, and Cell Death.

ACS bio & med chem Au·2023
Same journal

Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community.

The AAPS journal·2026
Same journal

In vivo Predictive Dissolution Test Using Biorelevant Bicarbonate Buffer for High-dose Free Acid Drug.

The AAPS journal·2026
Same journal

Whole-Body Pharmacokinetics of Ionizable Lipid, mRNA, and the Expressed Antibody following Intravenous Administration of mRNA-Loaded Lipid Nanoparticles.

The AAPS journal·2026
Same journal

Simple Hydrodynamic Molecular Weight Model for Rapid Assessment of Therapeutic Protein Oligomerization States in Formulation.

The AAPS journal·2026
Same journal

Guiding the Molnupiravir Tablet Formulation Using Physiologically Based Biopharmaceutics Modeling and Successfully Establishing Dissolution Safe Space.

The AAPS journal·2026
Same journal

Correction: Nanotechnology-enhanced Natural Products for Cancer Chemoprevention: Molecular Mechanisms and Clinical Translation.

The AAPS journal·2026
See all related articles

Related Experiment Video

Updated: Jul 18, 2025

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

11.0K

Nature vs. Manmade: Comparing Exosomes and Liposomes for Traumatic Brain Injury.

Kate Hennigan1, Erin Lavik2

  • 1Marriotts Ridge High School, Ellicott City, Maryland, 21042, USA.

The AAPS Journal
|August 23, 2023
PubMed
Summary
This summary is machine-generated.

Mesenchymal stem cell-derived exosomes show greater potential than liposomes for treating traumatic brain injury (TBI). Exosomes offer enhanced neural regeneration and fewer side effects, making them a promising nanocarrier for TBI therapy.

Keywords:
drug deliveryon-demand deliverypolymerstem cellstargeting

More Related Videos

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
07:21

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

3.2K
Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury
05:19

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury

Published on: October 18, 2024

699

Related Experiment Videos

Last Updated: Jul 18, 2025

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

11.0K
Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
07:21

Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury

Published on: May 27, 2022

3.2K
Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury
05:19

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury

Published on: October 18, 2024

699

Area of Science:

  • Neuroscience
  • Biotechnology
  • Drug Delivery

Background:

  • Traumatic brain injury (TBI) presents a significant public health challenge, with diverse outcomes impacting quality of life.
  • Liposomes and mesenchymal stem cell-derived exosomes are nanocarriers explored for TBI treatment, offering therapeutic benefits and enhanced drug efficacy.
  • Both nanocarriers share physical similarities but possess distinct properties influencing their performance in TBI applications.

Purpose of the Study:

  • To compare liposomes and exosomes as nanocarriers for traumatic brain injury (TBI) treatment.
  • To evaluate the therapeutic potential and delivery characteristics of liposomes versus exosomes for TBI.
  • To determine the optimal nanocarrier for TBI therapy based on efficacy, safety, and regenerative capabilities.

Main Methods:

  • Comparative analysis of liposome and exosome properties as nanocarriers.
  • Review of preclinical and clinical trial data for liposomes and exosomes in brain injury contexts.
  • Evaluation of drug encapsulation efficiency, targeting moieties, neural regeneration potential, and infusion reactions.

Main Results:

  • Liposomes offer higher encapsulation efficiency and commercial scalability.
  • Exosomes possess intrinsic cargo and targeting for neural regeneration and avoid infusion reactions.
  • Both nanocarriers can be targeted for increased brain accumulation, with potential for on-demand drug release.

Conclusions:

  • Exosomes demonstrate superior potential as nanocarriers for TBI treatment due to their regenerative capacity and safety profile.
  • While liposomes have advantages in production and encapsulation, exosomes' intrinsic properties are more beneficial for neural repair in TBI.
  • Further research and clinical application are warranted, but current evidence favors exosomes for TBI nanomedicine.